Division of Molecular Oncology, Hokkaido University, Sapporo 060-0815, Japan; Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Division of Molecular Oncology, Hokkaido University, Sapporo 060-0815, Japan.
Cell Rep. 2018 Jun 26;23(13):3721-3729. doi: 10.1016/j.celrep.2018.05.081.
p53 is a tumor suppressor protein, and its missense mutations are frequently found in human cancers. During the multi-step progression of cancer, p53 mutations generally accumulate at the mid or late stage, but not in the early stage, and the underlying mechanism is still unclear. In this study, using mammalian cell culture and mouse ex vivo systems, we demonstrate that when p53R273H- or p53R175H-expressing cells are surrounded by normal epithelial cells, mutant p53 cells undergo necroptosis and are basally extruded from the epithelial monolayer. When mutant p53 cells alone are present, cell death does not occur, indicating that necroptosis results from cell competition with the surrounding normal cells. Furthermore, when p53R273H mutation occurs within RasV12-transformed epithelia, cell death is strongly suppressed and most of the p53R273H-expressing cells remain intact. These results suggest that the order of oncogenic mutations in cancer development could be dictated by cell competition.
p53 是一种肿瘤抑制蛋白,其错义突变经常在人类癌症中发现。在癌症的多步进展过程中,p53 突变通常在中晚期累积,但不在早期累积,其潜在机制仍不清楚。在这项研究中,我们使用哺乳动物细胞培养和小鼠 ex vivo 系统,证明了当表达 p53R273H 或 p53R175H 的细胞被正常上皮细胞包围时,突变型 p53 细胞发生坏死性凋亡,并从上皮细胞单层中基础排出。当只有突变型 p53 细胞存在时,不会发生细胞死亡,这表明坏死性凋亡是由与周围正常细胞的细胞竞争引起的。此外,当 RasV12 转化的上皮细胞中发生 p53R273H 突变时,细胞死亡受到强烈抑制,并且大多数表达 p53R273H 的细胞保持完整。这些结果表明,癌症发展中致癌突变的顺序可能由细胞竞争决定。